Try our Advanced Search for more refined results

Deals Rumor Mill: Mylan, Lear, Iliad

By Benjamin Horney (August 20, 2014, 6:49 PM EDT) -- Generic-drug producer Mylan Inc., undisclosed Indian drugmakers, and private equity firms TPG Capital LLP, Advent International, KKR & Co. LP and Warburg Pincus LLC have made it to the second round of bidding for a mature drug portfolio being offered by GlaxoSmithKline PLC, The Wall Street Journal reported Wednesday. GSK's portfolio includes prescription medicine brands — such as the antidepressant drug Paxil and the hepatitis B drug Zeffix — that have annual sales of about $1.66 billion, according to WSJ. The sale price could end up being worth more than $3 billion, the report said....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!